LINCS MCF 10A Common Project: Fixed-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Repeat performed by Scientist B in 2019 to assess reproducibility. Dataset 1 of 2: Normalized growth rate inhibition values. - Dataset (ID:20359)

 Full screen view
Filter results: >>>>
Small Molecule barcode cell_count frac_dead corpse_count cell_count_dead row column agent concentration role timepoint replicate cell_line dead_count fraction_dead cell_count__time0 dead_count__time0 cell_count__ctrl dead_count__ctrl fraction_dead__ctrl increase_fraction_dead GRvalue
Trametinib
180703_BG_11
 19676 0.0252 142 357 14 19
Trametinib
0.000332667
treatment
 72 3
MCF10A-GM_6
 499 0.0247 1387.8 74.9 21564 711.9 0.0318 -0.00707 0.9542
Etoposide
180622_BG_7
 751 0.1729 76 67 14 4
Etoposide
3.193598006
treatment
 72 2
MCF10A-GM_5
 143 0.1600 832.0 168.3 20016 537.9 0.0261 0.13383 -0.0221
Alpelisib
180622_BG_6
 19252 0.0264 95 416 14 3
Alpelisib
0.033266667
treatment
 72 2
MCF10A-GM_3
 511 0.0259 832.0 168.3 20016 537.9 0.0261 -0.00027 0.9831
Trametinib
180622_BG_6
 1799 0.0782 119 31 14 14
Trametinib
0.031603332
treatment
 72 2
MCF10A-GM_3
 150 0.0770 832.0 168.3 20016 537.9 0.0261 0.05084 0.1830
Etoposide
180614_BG_03
 986 0.1017 86 23 14 4
Etoposide
3.193598006
treatment
 72 1
MCF10A-GM_5
 109 0.0995 889.0 105.5 17054 348.0 0.0200 0.07955 0.0246
Taxol
180614_BG_04
 454 0.7472 175 295 14 15
Paclitaxel
0.312706472
treatment
 72 1
MCF10A-GM_8
 470 0.5087 889.0 105.5 17054 348.0 0.0200 0.48866 -0.1459